Aysegul Ulu-Kilic
Overview
Explore the profile of Aysegul Ulu-Kilic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gundogdu A, Karis G, Killpartrick A, Ulu-Kilic A, Nalbantoglu O
Mol Nutr Food Res
. 2024 Jun;
68(12):e2300780.
PMID: 38856022
While probiotics are generally considered safe, concerns persist regarding the accuracy of labels on these supplements and their potential contribution to the spread of antibiotic resistance genes. Given that probiotics...
2.
Eryilmaz-Eren E, Koker M, Ulu-Kilic A, Hurmet-Oz H, Ay-Altintop Y, Saatci E, et al.
Infect Dis Clin Microbiol
. 2024 Apr;
5(1):23-30.
PMID: 38633909
Objective: Most patients with coronavirus disease (COVID-19) have abnormalities of lymphocyte subsets. This study aimed to determine the distribution of lymphocytes in patients with various severity levels of COVID-19 and...
3.
Ture Z, Unuvar G, Esmaoglu A, Ulu-Kilic A, Coruh A, Doganay M
J Wound Care
. 2023 Aug;
32(8):492-499.
PMID: 37572342
Objective: To assess the demographic and clinical characteristics, laboratory findings, and economic burden of patients with a diagnosis of complicated skin and soft tissue infection (cSSTI). Method: The demographic and...
4.
Eryilmaz-Eren E, Izci F, Ture Z, Sagiroglu P, Kaynar L, Ulu-Kilic A
Infect Chemother
. 2022 Sep;
54(3):446-455.
PMID: 36047301
Background: Bacteremia is a common complication in hematopoietic stem cell transplant (HSCT) recipients. Prophylactic fluoroquinolone is recommended and used in these individuals. Breakthrough infections can occur with fluoroquinolone-resistant strains. We...
5.
Celik I, Eryilmaz-Eren E, Kilinc-Toker A, Eren D, Yildiz M, Kanat A, et al.
Int J Clin Pract
. 2021 Oct;
75(12):e14997.
PMID: 34714574
Background: Respiratory failure and death are the leading causes of severe Coronavirus disease 2019 (COVID-19). Hyper-inflammation and cytokine storm cause lung damage. This study aimed to compare the low-dose and...
6.
Eren E, Ulu-Kilic A, Korkmaz S, Yildiz M, Yuksel R, Kilinc-Toker A, et al.
Sao Paulo Med J
. 2021 Sep;
140(1):12-16.
PMID: 34468633
Background: Coronavirus disease 2019 (COVID-19) is an ongoing global health threat. However, currently, no standard therapy has been approved for the disease. Objectives: To evaluate the clinical effectiveness of convalescent...
7.
Kelesoglu S, Yilmaz Y, Ozkan E, Calapkorur B, Dursun Z, Ulu-Kilic A, et al.
Biomark Med
. 2021 Aug;
15(13):1167-1175.
PMID: 34406031
To investigate whether C-reactive protein/albumin ratio (CAR) has an association with new onset atrial fibrillation (NOAF) in SARS-CoV-2. This study included 782 patients with SARS-CoV-2 infection, who were hospitalized in...
8.
Sulaiman T, Medi S, Erdem H, Senbayrak S, Ozturk-Engin D, Inan A, et al.
BMC Infect Dis
. 2020 Oct;
20(1):788.
PMID: 33096990
Background: Tuberculous meningitis (TBM) represents a diagnostic and management challenge to clinicians. The "Thwaites' system" and "Lancet consensus scoring system" are utilized to differentiate TBM from bacterial meningitis but their...
9.
Dursun Z, Ulu-Kilic A, Alabay S, Benli A, Celik I
Travel Med Infect Dis
. 2020 Sep;
37:101860.
PMID: 32889103
No abstract available.
10.
Diktas H, Uysal S, Erdem H, Cag Y, Miftode E, Durmus G, et al.
Eur J Clin Microbiol Infect Dis
. 2019 Dec;
39(4):689-701.
PMID: 31823148
We aimed to develop a scoring system for predicting in-hospital mortality of community-acquired (CA) sepsis patients. This was a prospective, observational multicenter study performed to analyze CA sepsis among adult...